MADRID (Reuters) – Spain has decided to remove an upper age limit of 65 years on AstraZeneca’s COVID-19 vaccine and give Johnson & Johnson’s version of the jab to people aged over 66, Cadena Ser radio reported on Tuesday.
A public health commission approved the change at a meeting on Tuesday, the broadcaster said, citing a document it had seen, a week after Spain decided to reintroduce the AstraZeneca treatment for people aged 18-65.
Several European countries had suspended administering the shot over concerns related to cases of blood clots.
(Reporting by Nathan Allen, writing by Isla Binnie; Editing by Andrei Khalip)